COMPARISON OF THE PHARMACOKINETICS AND SAFETY OF LIQUID (30 µg) AND LYOPHILIZED TETRODOTOXIN (15 µg AND 30 µg) FOLLOWING SINGLE AND TWICE DAILY SUBCUTANEOUS DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS-DETERMINATIONS IN BLOOD AND URINE
Latest Information Update: 24 Aug 2020
At a glance
- Drugs Tetrodotoxin (Primary)
- Indications Arrhythmias; Cancer pain; Neuropathic pain
- Focus Pharmacokinetics
Most Recent Events
- 30 Sep 2016 Results assessing safety presented at the 16th World Congress on Pain
- 07 Feb 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 07 Feb 2012 Actual initiation date (December 2011) and actual patient no 44 added as reported by ClinicalTrials.gov.